Author:
Bester Nicolette,Di Vito-Smith Michelle,McGarry Theresa,Riffkin Michael,Kaehler Stefan,Pilot Richard,Bwire Robert
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference13 articles.
1. Banerjee AK, Zomerdijk IM, Wooder S, Ingate S, Mayall SJ. Post-approval evaluation of effectiveness of risk minimisation: methods, challenges and interpretation. Drug Saf. 2014;37:33–42.
2. Edwards B, Chakraborty S. Risk communication and the pharmaceutical industry: what is the reality? Drug Saf. 2012;35:1027–40.
3. Giguère A, Légaré F, Grimshaw J, et al. Printed educational materials: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012;10:CD004398.
4. European Medicines Agency. Guideline on good pharmacovigilance practice (GVP). http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/02/WC500162051.pdf . Accessed 4 Nov 2015.
5. Council for International Organization of Medical Sciences (CIOMS). Practical approaches to risk minimisation for medicinal products: report of CIOMS working group IX. http://www.cioms.ch/index.php/publications/available-publications/540/view_bl/62/drug-development-and-use/40/practical-approaches-to-risk-minimisation-for-medicinal-products-report-of-cioms-working-group-ix?tab=getmybooksTab&is_show_data=1 . Accessed 4 Nov 2015.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献